UNSPSC 51152037: Mephenoxalone

This classification denotes a muscle relaxant with the molecular formula C11H13NO4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier CZ87T54W8W, chemically known as 2-oxazolidinone, 5-((o-methoxyphenoxy)methyl)- but generally known as mephenoxalone, which bears US NIH Compound Identifier 6257. European Medicines Agency schedules Mephenoxalone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08747MIG.

UNSPSC 51152037 Mephenoxalone is a Commodity code nominally covering pharmaceutical compounds, but the recent state and local solicitation activity under this code shows minimal relevance to the code's stated scope. Seminole County, Florida's IFB60459723LAS sought naloxone and drug deactivation systems for community health initiatives—a procurement addressing opioid overdose response and harm reduction rather than mephenoxalone supply. The county required 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, and bidders were required to submit electronic bids through the county's e-Procurement Portal, include all shipping and delivery costs, and comply with E-Verify and drug-free workplace certification. The contract structure included an initial two-year term with a one-year renewal option, a three-month probationary period allowing termination at will, and compliance with federal regulations tied to potential FEMA funding.

The source provides one recent opportunity from a single Florida county, with no evidence of broader state or regional concentration under this code. The mismatch between the code's nominal pharmaceutical substance scope and the actual procurement—which centers on naloxone (an opioid antagonist) and drug deactivation systems rather than mephenoxalone—suggests either a coding error in the state or local system or minimal genuine activity under this Commodity code. Firms evaluating pursuit should treat this code as showing insufficient recent activity to support procurement strategy; the single recorded opportunity does not establish a pattern of state and local buying in the code's stated product category.